Stem Cells and Gene Therapy in Progressive Hearing Loss: the State of the Art.

J Assoc Res Otolaryngol

Department of Otolaryngology-Head and Neck Surgery, University of Miami Miller School of Medicine, 1120 NW 14th Street, 5th Floor, Miami, FL, 33136, USA.

Published: April 2021

AI Article Synopsis

  • Progressive non-syndromic sensorineural hearing loss (PNSHL) is a prevalent sensory impairment in older adults, impacting over a third of those aged 65 and above, and includes conditions like noise-induced hearing loss and genetic forms such as delayed-onset autosomal dominant hearing loss.
  • PNSHL is considered a strong candidate for genetic therapies due to extensive research and the opportunity to intervene before significant hearing loss occurs, with various gene therapy strategies available, including viral and non-viral methods as well as gene editing techniques.
  • To effectively develop and test these therapies, creating a reliable in vitro model of the human inner ear from induced pluripotent stem cells (iPSCs) is essential, which could lead to

Article Abstract

Progressive non-syndromic sensorineural hearing loss (PNSHL) is the most common cause of sensory impairment, affecting more than a third of individuals over the age of 65. PNSHL includes noise-induced hearing loss (NIHL) and inherited forms of deafness, among which is delayed-onset autosomal dominant hearing loss (AD PNSHL). PNSHL is a prime candidate for genetic therapies due to the fact that PNSHL has been studied extensively, and there is a potentially wide window between identification of the disorder and the onset of hearing loss. Several gene therapy strategies exist that show potential for targeting PNSHL, including viral and non-viral approaches, and gene editing versus gene-modulating approaches. To fully explore the potential of these therapy strategies, a faithful in vitro model of the human inner ear is needed. Such models may come from induced pluripotent stem cells (iPSCs). The development of new treatment modalities by combining iPSC modeling with novel and innovative gene therapy approaches will pave the way for future applications leading to improved quality of life for many affected individuals and their families.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943682PMC
http://dx.doi.org/10.1007/s10162-020-00781-0DOI Listing

Publication Analysis

Top Keywords

hearing loss
20
gene therapy
12
stem cells
8
loss pnshl
8
therapy strategies
8
pnshl
6
hearing
5
loss
5
gene
4
cells gene
4

Similar Publications

Dementia Care Research and Psychosocial Factors.

Alzheimers Dement

December 2024

Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Background: Hearing rehabilitation has been a promising approach to improve cognitive outcomes. An ongoing study identified some barriers to engage patients in counseling sessions and using their hearing devices. Here we present the results from the first stage of a Sense-Cog Brazil pilot study, the recruitment phase.

View Article and Find Full Text PDF

Background: Our authors from around the world met to summarise the available knowledge, decide which potentially modifiable risk factors for dementia have compelling evidence and create the most comprehensive analysis to date for potentially modifiable risk factors to inform policy, give individuals the opportunity to control their risks and generate research.

Method: We incorporated all risk factors for which we judged there was strong enough evidence. We used the largest recent worldwide meta-analyses for risk factor prevalence and relative risk and if not available the best data.

View Article and Find Full Text PDF

Background: The 2020 Lancet Commission on dementia prevention, intervention and care estimated that up to 40% of dementia cases could be prevented by tackling 12 potentially modifiable risk factors, namely less education, hearing loss, hypertension, physical inactivity, diabetes, social isolation, excessive alcohol consumption, air pollution, smoking, obesity, traumatic brain injury, depression. As more evidence on risk factors emerges, the Lancet standing commission on dementia met to update evidence on established dementia risk factors and to consider the evidence for other risk factors.

Method: We used a lifecourse approach to understand how to reduce risk or prevent dementia, as many risks operate at different timepoints in the lifespan.

View Article and Find Full Text PDF

Dementia Care Research and Psychosocial Factors.

Alzheimers Dement

December 2024

Music and Health Science Research Collaboratory, University of Toronto, ON, Canada.

Background: The dual-cyclical relationship between language and cognition, encapsulated in linguistic relativity, underscores the reciprocal influence of thoughts on communication and vice-versa. This study explores the intricate changes in pragmatics, a fundamental aspect of human communication, during the aging process, considering changes in sensory abilities, cognition, and language.

Method: Sixty participants, aged ≥50 years with a minimum of five years of formal education, were included, excluding those with neurological or psychological illnesses.

View Article and Find Full Text PDF

Dementia Care Practice.

Alzheimers Dement

December 2024

Audition Technology, Pittsburgh, PA, USA.

The recent ACHIEVE study (https://www.achievestudy.org/) demonstrated the substantial benefit of hearing aid use in those with mild-moderate hearing loss and at increased risk for cognitive decline.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!